NEW YORK (GenomeWeb News) – Seeking to set a standard for how molecular diagnostic cancer tests are evaluated, the Center for Medical Technology Policy has issued a set of recommendations covering how to best assess the clinical validity and utility of these tests.

While molecular diagnostic tests offer great promise for oncology, evidence supporting the use and safety of these tests is lacking, and there is "considerable debate" about how much evidence is required and how it should be acquired, CMTP said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.